💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for CytRx Corporation (CYTR)
« Back to company indexCYTR Chatter Timeline
Stock Ticker for CYTR
Most Active Tweeters for CYTR
| User | Tweets |
|---|---|
| @FlashAlert_me | 4 |
| @newsfilterio | 4 |
| @InsiderAlerts4U | 2 |
| @ontrack9_oktogo | 2 |
| @coolcarlos27 | 1 |
Recent Tweets for CYTR
 |
@letitride1012 RT @ontrack9_oktogo: $CYTR 's press release in 2016 - that Aldoxorubicin was dosing at that time up to 6500 mg/m2 with NO CARDIO TOXICITY &… January 25th 2022, 6:01pm |
 |
@ontrack9_oktogo $CYTR 's press release in 2016 - that Aldoxorubicin was dosing at that time up to 6500 mg/m2 with NO CARDIO TOXICIT… https://t.co/Zhi0pe3f8K January 24th 2022, 1:01pm |
 |
@newsfilterio Form PRE 14A (other preliminary proxy statements) filed with the SEC $CYTR https://t.co/hp5GKVW59b January 21st 2022, 9:01pm |
 |
@FlashAlert_me $CYTR [15s. delayed] filed form PRE 14A on January 21, 16:05:15 https://t.co/NZDUsXcHnW January 21st 2022, 9:01pm |
|
@ontrack9_oktogo @DrPatSoonShiong Buy them out. $CYTR shareholders want out. You have managed to high roll the patent into your Can… https://t.co/VIRcrjQiG2 January 21st 2022, 1:01pm |
|
@newsfilterio CytRx to Hold Town Hall for Stockholders on Thursday, January 20th $CYTR https://t.co/mIyOCj30Vt January 19th 2022, 4:01am |
 |
@StockNewsBot2 $CYTR CytRx to Hold Town Hall for Stockholders on Thursday, January 20th https://t.co/y00lk4LFKN January 18th 2022, 1:01pm |
 |
@coolcarlos27 $cytr #Bitcoin I’m bullish crypto but in the meantime I invest in these stocks that produce 100-1000% gains fairly… https://t.co/Kv8KQOjll1 January 17th 2022, 12:01am |
|
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $CYTR https://t.co/t9jhD9BEkl January 12th 2022, 4:01pm |
 |
@InsiderAlerts4U $CYTR: New Insider Filing on CYTRX CORP's Chief Executive Officer STEPHEN SNOWDY: https://t.co/Fib6u4NMGw January 12th 2022, 4:01pm |
|
@InsiderAlerts4U $CYTR: New Insider Filing on CYTRX CORP's Chief Executive Officer STEPHEN SNOWDY: https://t.co/c5b2ZeD1PR January 12th 2022, 4:01pm |
|
@FlashAlert_me $CYTR [15s. delayed] filed SEC form 4: Chief Executive Officer Snowdy Stephen: Transacted Derivative Securities on… https://t.co/kq5khjl6Sc January 12th 2022, 3:01pm |
|
@FlashAlert_me $CYTR [15s. delayed] filed SEC form 3: Chief Executive Officer Snowdy Stephen: https://t.co/LBqWhMthOj January 12th 2022, 3:01pm |
|
@FlashAlert_me $CYTR [15s. delayed] filed SEC form 4/A: Director Simpson Jennifer K.: Transacted Derivative Securities on 2021-12… https://t.co/TekLjjhs9E January 12th 2022, 2:01am |
|
@newsfilterio Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $CYTR https://t.co/lpu0oY30eq January 12th 2022, 2:01am |
 |
@dsrgvr The reported earnings of $CYTR in recent quarters seem unreasonable. The discretionary accruals are very high. Thes… https://t.co/Gfo2iTZTzz January 11th 2022, 8:01am |
|
@ontrack9_oktogo @DrPatSoonShiong Soon Shiong bombs $CYTR shareholders 2017 catches Aldoxorubicin - delays it, prevents it from goin… https://t.co/HnfvTpJzGP January 10th 2022, 4:01am |
 |
@1stOncology #CytRx to Participate in the #HCWainwrightBioConnect Virtual Conference $CYTR https://t.co/b8AxMSLhyq January 8th 2022, 7:01am |
|
@newsfilterio CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference $CYTR https://t.co/FMeMVPWtQI January 7th 2022, 6:01pm |
 |
@equity_newswire $CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/QwQZ6qgDGF January 7th 2022, 3:01pm |
 |
@gcassidy718 $CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/oQCcvZSEAs January 7th 2022, 1:01pm |
 |
@otcdynamics $CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/Su5d6u75GG January 7th 2022, 1:01pm |
|
@FlashAlert_me $CYTR [15s. delayed]: Issued Press Release on January 07, 08:00:00: CytRx to Participate in the H.C. Wainwright Bio… https://t.co/hLtJ3Luc1m January 7th 2022, 1:01pm |
|
@StockNewsBot2 $CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/I1p2xSrjtg January 7th 2022, 1:01pm |
 |
@bthefirsttoknow First out// $CYTR: CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference https://t.co/kZN0L9QGcb January 7th 2022, 1:01pm |
 |
@XBRhell @adamfeuerstein can we get a tweet about $CYTR Steve Kriegsman's $6MM lump sum severance? Over 36% of cash as of 9/… https://t.co/bF8cx850SE January 5th 2022, 3:01pm |
|
@coolcarlos27 $CYTR Told ya it doesn’t pay to ignore my calls $CREG January 4th 2022, 3:01pm |
|
@FlashAlert_me $CYTR [15s. delayed] filed form 8-K on January 04, 09:09:40 https://t.co/4T5ZK70DBX January 4th 2022, 2:01pm |
 |
@pablodesaavedra Finally good news in CYTRX an incompetent is leaving $cytr #aldoxorubicin #arimoclomol https://t.co/EvuNqZeyaR January 3rd 2022, 5:01pm |
|
@equity_newswire $CYTR CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/yLZrLiCdgv January 3rd 2022, 3:01pm |
|
@gcassidy718 $CYTR CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/f8FCyyzwjA January 3rd 2022, 1:01pm |
 |
@ScryingBiotech $CYTR Allegedly (as there’s no PR yet on the company website) CEO Steven Kriegsman is stepping down effective 1/10/… https://t.co/VuRIV8Tyy2 January 3rd 2022, 1:01pm |
 |
@otc_watch_news $CYTR #OTCQB CytRx Corp. (CYTR: OTCQB) | CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive… https://t.co/WIem9Xegj9 January 3rd 2022, 1:01pm |
|
@otcdynamics $CYTR CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/PTRtndWmz0 January 3rd 2022, 1:01pm |
|
@newsfilterio CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer $CYTR https://t.co/wZJWjtuMjJ January 3rd 2022, 1:01pm |
|
@FlashAlert_me $CYTR [15s. delayed]: Issued Press Release on January 03, 08:00:00: CytRx Announces the Appointment of Dr. Stephen… https://t.co/Zf1WekZPy9 January 3rd 2022, 1:01pm |
|
@StockNewsBot2 $CYTR CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer https://t.co/sZr8hQF0WZ January 3rd 2022, 1:01pm |
|
@coolcarlos27 #bitcoin I like this but not as much as the stocks I own $CREG $CYTR watch and learn from the best January 1st 2022, 6:01am |
 |
@StckPro $CYTR NEW ARTICLE : ImmunityBio pares gains following aldoxorubicin data in cancer https://t.co/9cZ5pGf4hd Get all… https://t.co/YtP2KH2cK5 December 28th 2021, 5:12pm |
 |
@PenkeTrading I found you a Death Cross on the daily chart of Cyclops Treasure. $CYTR $CYTR.CC #deathcross #bearish #crypto… https://t.co/yLMQq7R7O6 December 27th 2021, 2:12pm |
 |
@hephaistos_ai RT @1stOncology: #CytRx Highlights #ImmunityBios Use of #Aldoxorubicin in Ongoing Clinical Studies for Various Forms of #Cancer $CYTR $IBRX… December 22nd 2021, 10:12am |
|
@hephaistos_ai RT @1stOncology: #CytRx Highlights #ImmunityBios Use of #Aldoxorubicin in Ongoing Clinical Studies for Various Forms of #Cancer $CYTR https… December 22nd 2021, 10:12am |
|
@1stOncology #CytRx Highlights #ImmunityBios Use of #Aldoxorubicin in Ongoing Clinical Studies for Various Forms of #Cancer $CYTR https://t.co/m9kkF7Z9nj December 22nd 2021, 10:12am |
|
@sgre2893 Recent quarterly reports reveal $CYTR may be involved in profit manipulation. Its average discretionary accruals (t… https://t.co/UkvmvJ0YBR December 22nd 2021, 3:12am |
|
@equity_newswire $CYTR CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer https://t.co/0sHiP0PEuA December 21st 2021, 9:12pm |
|
@newsfilterio CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer $CYTR… https://t.co/aYqZ4CnMKM December 21st 2021, 7:12pm |
|
@gcassidy718 $CYTR CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer https://t.co/qyjkhbt0ty December 21st 2021, 3:12pm |
|
@otc_watch_news $CYTR #OTCQB CytRx Corp. (CYTR: OTCQB) | CytRx Highlights ImmunityBio’s Use of Aldoxorubicin in Ongoing Clinical St… https://t.co/nDqJw0hvic December 21st 2021, 1:12pm |
 |
@GapUp4 $CYTR $IBRX CytRx Highlights ImmunityBio's Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer December 21st 2021, 1:12pm |
|
@otcdynamics $CYTR CytRx Highlights ImmunityBio’s Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer https://t.co/IR7axGSzHq December 21st 2021, 1:12pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?